Cassava Sciences, Inc.
SAVA
$2.05
-$0.07-3.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 132.07% | -341.09% | |||
| Gross Profit | -132.07% | 341.09% | |||
| SG&A Expenses | 939.87% | -106.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.21% | -38.26% | |||
| Operating Income | -10.21% | 38.26% | |||
| Income Before Tax | 15.20% | 1.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.20% | 1.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.20% | 1.24% | |||
| EBIT | -10.21% | 38.26% | |||
| EBITDA | -10.55% | 38.57% | |||
| EPS Basic | 15.49% | 1.48% | |||
| Normalized Basic EPS | -14.87% | 39.22% | |||
| EPS Diluted | 15.49% | 1.48% | |||
| Normalized Diluted EPS | -14.87% | 39.22% | |||
| Average Basic Shares Outstanding | 0.34% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.34% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||